Good morning. I'm Marc Hertz, Chief Executive Officer of GRI Bio Incorporated, and I'm very happy to welcome you to the 2026 Annual Meeting of Stockholders of GRI Bio. I will act as Chairman of this meeting. Before proceeding to the business of the meeting, I'd like to introduce you to Leanne Kelly, Chief Financial Officer of the company, who will act as Secretary of the meeting. Also present today is Rob Thomas of WithumSmith+Brown, the company's auditors, and Melanie Ruthrauff Levy from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., the company's outside legal counsel. Gary Wozniak of Broadridge Corporate Issuer Solutions Inc. is also present and will act as the inspector of election for this meeting. This meeting is held pursuant to a printed notice mailed on or about September 28, 2026, to each stockholder of record on September 22, 2026, who is entitled to vote. The count of shares present immediately prior to the commencement of the meeting indicated that 926,474 shares of the company's voting capital stock were present in person or by proxy. This is 42.37% of the outstanding voting stock of the company. I hereby declare a quorum present at the meeting. On behalf of the Board of Directors of the company, I'd like to express my appreciation to all stockholders who returned their proxies. The first matter to be acted upon by the stockholders today is the re-election of two directors, W. Marc Hertz, PhD, and David Szekeres, each to serve until the annual meeting to be held in 2029 and until such person's successor has been elected and qualified. Additional information about each of the nominees is in the proxy statement. I hereby declare Dr. Hertz and Mr. Szekeres duly nominated. The company has not received timely notice of any other nominations. Therefore, I declare the nominations closed. The second matter being submitted to stockholders for action is the ratification of the appointment by the Board of Directors of WithumSmith+Brown PC as the company's auditors for the year ending December 31, 2026. The third matter being submitted to the stockholders for action is the approval of an amendment and restatement of the company's amended and restated 2018 Equity Incentive Plan, as amended, to increase the aggregate number of shares of common stock available for issuance thereunder by 546,529 and extend the evergreen provision to January 2036. The stockholders who are voting at the meeting on these proposals should now vote. Voting is by proxy and electronic ballot. You do not need to vote at this meeting if you've already submitted your signed proxy. Those of you who would like to vote today may do so by clicking on the button on your screen entitled "Vote Here." After voting has been completed, votes will be counted. Please vote on each proposal using the link provided in the webcast. At this time, I hereby declare the polls closed for all proposals. We will prepare the preliminary results of the voting at this time. Will the Secretary please report the preliminary results at this time? We have completed a preliminary count of the ballots, and the requisite votes have been voted for the election of the director nominees for a term expiring on the date of the Annual Meeting of Stockholders in 2029, have been voted for the ratification of the appointment of WithumSmith+Brown PC to audit the financial statements of the company and its subsidiaries for the year ended December 31, 2026, and have been voted for the amendment and restatement of the company's Amended and Restated 2018 Equity Incentive Plan, as amended, to increase the aggregate number of shares of common stock available for issuance thereunder by 546,529 and extend the evergreen provision to January 1, 2036. I hereby declare that the nominees for directors have been duly elected, the appointment of WithumSmith+Brown PC to audit the financial statements of the company and its subsidiaries has duly been ratified, and the amendment and restatement of the company's Amended and Restated 2018 Equity Incentive Plan, as amended, to increase the aggregate number of shares of common stock available for issuance thereunder by 546,529 and extend the evergreen provision to January 1, 2036, has been approved. After the final tabulation has been completed, it shall be placed with the minutes of this meeting. We expect to report our preliminary voting results, or if available to us on a timely basis, our final voting results on a current report on Form 8-K to be filed with the SEC within four business days after the date of this meeting. If not earlier reported, we expect to report our final voting results in an amendment to our current report on Form 8-K within four business days after the final results are known to us. I hereby formally adjourn the meeting. This concludes the formal portion of our meeting. We'd like to thank each of you for attending this stockholders' meeting.